Log in to save to my catalogue

Long-term glycemic control using polymer-encapsulated human stem cell–derived beta cells in immune-c...

Long-term glycemic control using polymer-encapsulated human stem cell–derived beta cells in immune-c...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4825868

Long-term glycemic control using polymer-encapsulated human stem cell–derived beta cells in immune-competent mice

About this item

Full title

Long-term glycemic control using polymer-encapsulated human stem cell–derived beta cells in immune-competent mice

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2016-03, Vol.22 (3), p.306-311

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

When encapsulated with alginate derivatives that resist the foreign-body response, human embryonic stem cell–derived beta cells restore long-term normoglycemia in immunocompetent mice without the need for immunosuppression.
The transplantation of glucose-responsive, insulin-producing cells offers the potential for restoring glycemic control in i...

Alternative Titles

Full title

Long-term glycemic control using polymer-encapsulated human stem cell–derived beta cells in immune-competent mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4825868

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4825868

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/nm.4030

How to access this item